| Mrs Cristina Marie Lister, FNP | |
|
7885 N Oracle Rd, Tucson, AZ 85704-6348 | |
| (520) 202-1585 | |
| (520) 202-1590 |
| Full Name | Mrs Cristina Marie Lister |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 7885 N Oracle Rd, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427698166 | NPI | - | NPPES |
| 003213 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 236329 (Arizona) | Secondary |
| 363L00000X | Nurse Practitioner | 236329 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marana Health Center Inc | 2365348091 | 83 |
News Archive
The research team drew on data from the Australian Longitudinal Study of Aging (ALSA), which began in 1992 in Adelaide, South Australia. The study aimed to assess how economic, social, behavioural and environmental factors affected the health and wellbeing of people aged 70 and upwards.
Surface-enhanced Raman spectroscopy is a highly sensitive molecule characterization method, significantly more sensitive than ordinary Raman spectroscopy due to the excitation of Raman modes matching the plasmon resonance frequency of the surface metal utilized, usually gold, silver, or copper.
Atox Bio, developer of therapeutics for diseases mediated by an excessive inflammatory response, today announced that it has raised $3.25 million in an initial closing. The investment was co-led by Esperante and a private US-based investor and will be used to advance AB103, currently in phase 2 clinical studies for the treatment of Necrotizing Soft Tissue Infections (NSTI).
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.
A novel cartilage degeneration algorithm can predict the progression of osteoarthritis in individual patients, according to new research from the University of Eastern Finland. The new algorithm could greatly facilitate clinical decision-making in the treatment of osteoarthritis.
› Verified 4 days ago
| Entity Name | Marana Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447263405 PECOS PAC ID: 2365348091 Enrollment ID: O20031211000790 |
News Archive
The research team drew on data from the Australian Longitudinal Study of Aging (ALSA), which began in 1992 in Adelaide, South Australia. The study aimed to assess how economic, social, behavioural and environmental factors affected the health and wellbeing of people aged 70 and upwards.
Surface-enhanced Raman spectroscopy is a highly sensitive molecule characterization method, significantly more sensitive than ordinary Raman spectroscopy due to the excitation of Raman modes matching the plasmon resonance frequency of the surface metal utilized, usually gold, silver, or copper.
Atox Bio, developer of therapeutics for diseases mediated by an excessive inflammatory response, today announced that it has raised $3.25 million in an initial closing. The investment was co-led by Esperante and a private US-based investor and will be used to advance AB103, currently in phase 2 clinical studies for the treatment of Necrotizing Soft Tissue Infections (NSTI).
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.
A novel cartilage degeneration algorithm can predict the progression of osteoarthritis in individual patients, according to new research from the University of Eastern Finland. The new algorithm could greatly facilitate clinical decision-making in the treatment of osteoarthritis.
› Verified 4 days ago
| Entity Name | Summit Medical Group Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053810622 PECOS PAC ID: 3173872835 Enrollment ID: O20180814003015 |
News Archive
The research team drew on data from the Australian Longitudinal Study of Aging (ALSA), which began in 1992 in Adelaide, South Australia. The study aimed to assess how economic, social, behavioural and environmental factors affected the health and wellbeing of people aged 70 and upwards.
Surface-enhanced Raman spectroscopy is a highly sensitive molecule characterization method, significantly more sensitive than ordinary Raman spectroscopy due to the excitation of Raman modes matching the plasmon resonance frequency of the surface metal utilized, usually gold, silver, or copper.
Atox Bio, developer of therapeutics for diseases mediated by an excessive inflammatory response, today announced that it has raised $3.25 million in an initial closing. The investment was co-led by Esperante and a private US-based investor and will be used to advance AB103, currently in phase 2 clinical studies for the treatment of Necrotizing Soft Tissue Infections (NSTI).
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.
A novel cartilage degeneration algorithm can predict the progression of osteoarthritis in individual patients, according to new research from the University of Eastern Finland. The new algorithm could greatly facilitate clinical decision-making in the treatment of osteoarthritis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cristina Marie Lister, FNP 7885 N Oracle Rd, Tucson, AZ 85704-6348 Ph: (520) 202-1585 | Mrs Cristina Marie Lister, FNP 7885 N Oracle Rd, Tucson, AZ 85704-6348 Ph: (520) 202-1585 |
News Archive
The research team drew on data from the Australian Longitudinal Study of Aging (ALSA), which began in 1992 in Adelaide, South Australia. The study aimed to assess how economic, social, behavioural and environmental factors affected the health and wellbeing of people aged 70 and upwards.
Surface-enhanced Raman spectroscopy is a highly sensitive molecule characterization method, significantly more sensitive than ordinary Raman spectroscopy due to the excitation of Raman modes matching the plasmon resonance frequency of the surface metal utilized, usually gold, silver, or copper.
Atox Bio, developer of therapeutics for diseases mediated by an excessive inflammatory response, today announced that it has raised $3.25 million in an initial closing. The investment was co-led by Esperante and a private US-based investor and will be used to advance AB103, currently in phase 2 clinical studies for the treatment of Necrotizing Soft Tissue Infections (NSTI).
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months.
A novel cartilage degeneration algorithm can predict the progression of osteoarthritis in individual patients, according to new research from the University of Eastern Finland. The new algorithm could greatly facilitate clinical decision-making in the treatment of osteoarthritis.
› Verified 4 days ago